ℹ️
🇬🇧
Search
Search for publications relevant for "ruxolitinib"
ruxolitinib
Publication
Class
Person
Publication
Programmes
Export current view
publication
Role of ruxolitinib in the treatment of primary myelofibrosis
2015 |
Faculty of Medicine in Hradec Králové
publication
Experience with ruxolitinib in the treatment of myelofibrosis and polycythaemia vera at Czech haematological institutions
2017 |
Faculty of Medicine in Hradec Králové
publication
Report of University Hospital Hradec Králové to the clinical trial protocol No: GS-US-352-0101
Publication without faculty affiliation
publication
Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation
2018 |
First Faculty of Medicine, Second Faculty of Medicine
publication
Neutrophils in STAT1 Gain-Of-Function Have a Pro-inflammatory Signature Which Is Not Rescued by JAK Inhibition
2023 |
Second Faculty of Medicine
publication
Immunoprofiling of monocytes in STAT1 gain-of-function chronic mucocutaneous candidiasis
2022 |
First Faculty of Medicine, Second Faculty of Medicine
publication
Aberrant tolerogenic functions and proinflammatory skew of dendritic cells in STAT1 gain-of-function patients may contribute to autoimmunity and fungal susceptibility
2023 |
Second Faculty of Medicine
publication
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry
2023 |
Publication without faculty affiliation
publication
Early-onset pulmonary and cutaneous vasculitis driven by constitutively active SRC-family kinase HCK
2022 |
Second Faculty of Medicine
publication
Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain of Function (GOF) Mutations-10 Children and Review of the Literature
2022 |
First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University
publication
JAK-inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID and EBMT IEWP retrospective study
2024 |
First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
publication
Treatment of polycythemia vera
2018 |
Faculty of Medicine in Hradec Králové
publication
Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients
2022 |
First Faculty of Medicine, Second Faculty of Medicine
publication
PH negative myeloproliferative neoplasms in Czech haematological centres - MIND analysis
2021 |
Faculty of Medicine in Hradec Králové
publication
Recommendations for the diagnosis and treatment of patients with polycythaemia vera
2018 |
First Faculty of Medicine
publication
Survival in primary hemophagocytic lymphohistiocytosis 2016-2021: etoposide is better than its reputation
2024 |
Second Faculty of Medicine